Skip to main content
SpringerLink
Log in

Cancers of the Intestine, the Liver, and the Biliary Tract

  • Chapter
  • First Online:
Occupational Cancers

  • 1023 Accesses

Abstract

Colorectal cancer is an important cancer worldwide, whose etiology is not fully understood. Known causes include several genetic factors, overweight/obesity, tobacco smoking, and heavy alcohol drinking. An etiologic role of diet is highly plausible but the evidence for specific factors, with the possible exception of processed meat, is not conclusive. Workers exposed to asbestos have been found at increased risk of colorectal cancer in several studies, but the evidence is not sufficiently strong to conclude in favor of a causal association. No other occupational factors have been linked to colorectal cancer. Liver cancer is a common cancer in many regions of the world and is the second cause of cancer-specific mortality. About 75% of liver cancers are hepatocellular carcinoma (HCC), the second most frequent type being cholangiocarcinoma (CCA). HCC develops in the context of a web of interactions between viral (HBV, HCV), environmental (alcohol, aflatoxin), and metabolic (fatty liver disease, obesity) factors. Genetic predisposition accounts for only a small fraction of the global burden of HCC. The only established occupational cause of liver cancer is vinyl chloride, which causes a rare type of neoplasm, angiosarcoma, and has also been associated with HCC. Detection and diagnosis of HCC is complicated by its occurrence in a background of chronic liver disease characterized by inflammation and cycles of hepatocyte proliferation and destruction. Markers used in clinical practice include serological and molecular markers of viral hepatitis, enzymatic tests for liver function and injury, and a growing list of plasma-based tumor markers, the current gold standard being alpha-fetoprotein (AFP). Recent research has identified molecular changes in transcriptome, microRNAome, epigenome and, significantly, plasma proteome, that pave the way to the development of a new generation of biomarkers for early detection of HCC in different etiological contexts.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase no. 11. Lyon, France: International Agency for Research on Cancer; 2013. http://globocan.iarc.fr.

    Google Scholar 

  2. Beebe-Dimer J, Schottenfeld D. Cancers of the small intestine. In: Schottenfeld D, Fraumeni JF, editors. Cancer epidemiology and prevention. New York: Oxford University Press; 2006. p. 801–8.

    Chapter  Google Scholar 

  3. Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R, Ferlay J. Cancer incidence in five continents, vol. 11 (electronic version). Lyon: International Agency for Research on Cancer; 2017. http://ci5.iarc.fr.

    Google Scholar 

  4. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: American Institute for Cancer Research; 2007.

    Google Scholar 

  5. International Agency for Research on Cancer. Tobacco smoke. In: IARC monographs on the evaluation of the carcinogenic risks to humans. Tobacco smoke and involuntary smoking, vol. 83. Lyon: International Agency for Research on Cancer; 2004. p. 51–1187.

    Google Scholar 

  6. Fedirko V, Tramacere I, Bagnardi V, et al. Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol. 2011;22:1958–72.

    Article  CAS  PubMed  Google Scholar 

  7. Giovannucci E, Wu K. Cancers of the colon and rectum. In: Schottenfeld D, Fraumeni JF, editors. Cancer epidemiology and prevention. New York: Oxford University Press; 2006. p. 809–29.

    Chapter  Google Scholar 

  8. Selikoff IJ, Churg J, Hammond EC. Asbestos exposure and neoplasia. JAMA. 1964;188:22–6.

    Article  CAS  PubMed  Google Scholar 

  9. Institute of Medicine. Asbestos: selected cancers. Washington, DC: National Academy Press; 2006.

    Google Scholar 

  10. International Agency for Research on Cancer. Asbestos. In: IARC monographs on the evaluation of carcinogenic risks to humans, volume 100—a review of human carcinogens, part C: arsenic, metals, fibres, and dusts. Lyon: International Agency for Research on Cancer; 2012. p. 219–310.

    Google Scholar 

  11. Paris C, Thaon I, Herin F, et al. Occupational asbestos exposure and incidence of colon and rectal cancers in French men: the asbestos-related diseases cohort (ARDCo-Nut). Environ Health Perspect. 2017;125:409–5.

    Article  PubMed  Google Scholar 

  12. Kjarheim K, Ulvestad B, Martinsen JI, Andersen A. Cancer of the gastrointestinal tract and exposure to asbestos in drinking water among lighthouse keepers (Norway). Cancer Causes Control. 2005;16:593–8.

    Article  Google Scholar 

  13. Thygesen LC, Albertsen K, Johansen C, Grønbaek M. Cancer incidence among Danish brewery workers. Int J Cancer. 2005;116:774–8.

    Article  CAS  PubMed  Google Scholar 

  14. Pukkala E, Martinsen JI, Lynge E, et al. Occupation and cancer—follow-up of 15 million people in five Nordic countries. Acta Oncol. 2009;48:646–790.

    Article  CAS  PubMed  Google Scholar 

  15. Hogstedt C, Jansson C, Hugosson M, Tinnerberg H, Gustavsson P. Cancer incidence in a cohort of Swedish chimney sweeps, 1958–2006. Am J Public Health. 2013;103:1708–14.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Oddone E, Modonesi C, Gatta G. Occupational exposures and colorectal cancers: a quantitative overview of epidemiological evidence. World J Gastroenterol. 2014;20(35):12431–44.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Theise ND, Curado MP, Franceschi S, et al. Hepatocellular carcinoma. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system. 4th ed. Lyon: International Agency for Research on Cancer; 2010. p. 205–16.

    Google Scholar 

  18. Nakanuma Y, Curado MP, Franceschi S, Gores G, Paradis V, Sripa B, Tsui WMS, Wee A. WHO classification of tumours of the digestive system. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. Intrahepatic cholangiocarcinoma. 4th ed. Lyon: International Agency for Research on Cancer; 2010. p. 217–24.

    Google Scholar 

  19. Miettinen M, Fletcher CDM, Kindblom LG, Zimmermann A, Tsui WMS. WHO classification of tumours of the digestive system. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. Mesenchymal tumours of the liver. 4th ed. Lyon: International Agency for Research on Cancer; 2010. p. 241–50.

    Google Scholar 

  20. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118:3030–44.

    Article  CAS  PubMed  Google Scholar 

  21. Block JB. Angiosarcoma of the liver following vinyl chloride exposure. JAMA. 1974;229:53–4.

    Article  CAS  PubMed  Google Scholar 

  22. Boffetta P, Matisane L, Mundt KA, Dell LD. Metaanalysis of studies of occupational exposure to vinyl chloride in relation to cancer mortality. Scand J Work Environ Health. 2003;29:220–9.

    Article  CAS  PubMed  Google Scholar 

  23. Mundt KA, Dell LD, Austin RP, et al. Historical cohort study of 10 109 men in the North American vinyl chloride industry, 1942–72: update of cancer mortality to 31 December 1995. Occup Environ Med. 2000;57:774–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Ward E, Boffetta P, Andersen A, et al. Update of the follow-up of mortality and cancer incidence among European workers employed in the vinyl chloride industry. Epidemiology. 2001;12:710–8.

    Article  CAS  PubMed  Google Scholar 

  25. Mundt KA, Dell DL, Crawford L, et al. Quantitative estimated exposure to vinyl chloride and risk of angiosarcoma of the liver and hepatocellular cancer in the US industry-wide vinyl chloride cohort: mortality update through 2013. Occup Environ Med. 2017;74:709–16.

    Article  PubMed  Google Scholar 

  26. Bosetti C, La Vecchia C, Lipworth L, McLaughlin JK. Occupational exposure to vinyl chloride and cancer risk: a review of the epidemiologic literature. Eur J Cancer Prev. 2003;12:427–30.

    Article  CAS  PubMed  Google Scholar 

  27. Carreón T, Hein MJ, Hanley KW, et al. Coronary artery disease and Cancer mortality in a cohort of workers exposed to vinyl chloride, carbon disulfide, rotating shift work, and o-toluidine at a chemical manufacturing plant. Am J Ind Med. 2014;57:398–411.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  28. International Agency for Research on Cancer. Vinyl chloride. In: IARC monographs on the evaluation of carcinogenic risks to humans, volume 100—a review of human carcinogens, part F: chemical agents and related occupations. Lyon: International Agency for Research on Cancer; 2012. p. 415–78.

    Google Scholar 

  29. Pirastu R, Baccini M, Biggeri A, Comba P. Epidemiologic study of workers exposed to vinyl chloride in Porto Marghera: mortality update. Epidemiol Prev. 2003;27:161–72.

    PubMed  Google Scholar 

  30. Wong RH, Chen PC, Wang JD, Du CL, Cheng TJ. Interaction of vinyl chloride monomer exposure and hepatitis B viral infection on liver cancer. J Occup Environ Med. 2003;45:379–83.

    Article  CAS  PubMed  Google Scholar 

  31. Mastrangelo G, Fedeli U, Fadda E, et al. Increased risk of hepatocellular carcinoma and liver cirrhosis in vinyl chloride workers: synergisticeffect of occupational exposure with alcohol intake. Environ Health Perspect. 2004;112:1188–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. International Agency for Research on Cancer. Trichloroethylene. In: IARC monographs on the evaluation of carcinogenic risks to humans, volume 106, Tetrachloroethylene, and some other chlorinated agents. Lyon: International Agency for Research on Cancer; 2014. p. 26–218.

    Google Scholar 

  33. Hansen J, Sallmén M, Seldén AI, et al. Risk of cancer among workers exposed to trichloroethylene: analysis of three Nordic cohort studies. J Natl Cancer Inst. 2013;105:869–77.

    Article  PubMed  Google Scholar 

  34. International Agency for Research on Cancer. Tetrachloroethylene. In: IARC monographs on the evaluation of carcinogenic risks to humans, volume 106, Tetrachloroethylene, and some other chlorinated agents. Lyon: International Agency for Research on Cancer; 2014. p. 219–352.

    Google Scholar 

  35. Vlaanderen J, Straif K, Pukkala E, et al. Occupational exposure to trichloroethylene and perchloroethylene and the risk of lymphoma, liver, and kidney cancer in four Nordic countries. Occup Environ Med. 2013;70:393–401.

    Article  PubMed  Google Scholar 

  36. Silver S, Pinkerton LE, Donald A. Retrospective cohort study of a microelectronics and business machine facility. Am J Ind Med. 2014;57:412–24.

    Article  PubMed  Google Scholar 

  37. Lanes SF, Rothman KJ, Dreyer NA, Soden KJ. Mortality update of cellulose fiber production workers. Scand J Work Environ Health. 1993;19:426–8.

    Article  CAS  PubMed  Google Scholar 

  38. Liu T, Xu QE, Zhang CH, Zhang P. Occupational exposure to methylene chloride and risk of cancer: a meta-analysis. Cancer Causes Control. 2013;24:2037–49.

    Article  PubMed  Google Scholar 

  39. Autrup JL, Schmidt J, Autrup H. Exposure to aflatoxin B1 inanimal-feed production plant workers. Environ Health Perspect. 1993;99:195–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Kauppinen T, Riala R, Seitsamo J, Hernberg S. Primary livercancer and occupational exposure. Scand J Work Environ Health. 1992;18:18–25.

    Article  CAS  PubMed  Google Scholar 

  41. Alavanja MC, Malker H, Hayes RB. Occupational cancer risk associated with the storage and bulk handling of agricultural foodstuff. J Toxicol Environ Health. 1987;22:247–54.

    Article  CAS  PubMed  Google Scholar 

  42. Kumagai S, Kurumatani N, Arimoto A, et al. Cholangiocarcinoma among offset colour proof-printing workers exposed to 1,2-dichloropropane and/or dichloromethane. Occup Environ Med. 2013;70:508–10.

    Article  CAS  PubMed  Google Scholar 

  43. Kubo S, Nakanuma Y, Takemura S, et al. Case series of 17 patients with cholangiocarcinoma among young adult workers of a printing company in Japan. J Hepatobiliary Pancreat Sci. 2014;21:479–88.

    Article  PubMed  Google Scholar 

  44. Kumagai S, Sobue T, Makiuchi T, et al. Relationship between cumulative exposure to 1,2dichloropropane and incidence risk of cholangiocarcinoma among offset printing workers. Occup Environ Med. 2016;73:545–52.

    Article  PubMed  Google Scholar 

  45. OkamotoE KK, Endo G. Prevalence of bile duct cancer among printing industry workers in comparison with other industries. J Occup Health. 2013;55:511–5.

    Article  Google Scholar 

  46. Vlaanderen J, Straif K, Martinsen JI. Cholangiocarcinoma among workers in the printing industry: using the NOCCA database to elucidate the generalisability of a cluster report from Japan. Occup Environ Med. 2013;70:828–83.

    Article  PubMed  Google Scholar 

  47. Ahrens W, Merletti F, Mirabelli D. Biliary tract cancer in male printers and typesetters in the European rare cancer case-control study. Occup Environ Med. 2014;71:591–2.

    Article  PubMed  Google Scholar 

  48. Brandi G, Di Girolamo S, Farioli A. Asbestos: a hidden player behind the cholangiocarcinoma increase? Findings from a case–control analysis. Cancer Causes Control. 2013;24:911–8.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Farioli A, Straif K, Brandi G, et al. Occupational exposure to asbestos and risk of cholangiocarcinoma: a population-based case-control study in four Nordic countries. Occup Environ Med. 2018. (in press;75:191.

    Article  PubMed  Google Scholar 

  50. Boulanger M, Morlais F, Bouvier V, et al. Digestive cancers and occupational asbestos exposure: incidence study in a cohort of asbestos plant workers. Occup Environ Med. 2015;72:792–7.

    Article  PubMed  Google Scholar 

  51. Laurent-Puig P, Zucman-Rossi J. Genetics of hepatocellular tumors. Oncogene. 2006;25:3778–86.

    Article  CAS  PubMed  Google Scholar 

  52. Tokino T, Tamura H, Hori N, Matsubara K. Chromosome deletions associated with hepatitis B virus integration. Virology. 1991;185:879–82.

    Article  CAS  PubMed  Google Scholar 

  53. Murakami Y, Saigo K, Takashima H, et al. Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut. 2005;54:1162–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Tarn C, Lee S, Hu Y, Ashendel C, Andrisani OM. Hepatitis B virus X protein differentially activates RAS-RAF-MAPK and JNK pathways in X-transforming versus non-transforming AML12 hepatocytes. J Biol Chem. 2001;276:34671–80.

    Article  CAS  PubMed  Google Scholar 

  55. Feitelson MA, Sun B, Satiroglu Tufan NL, et al. Genetic mechanisms of hepatocarcinogenesis. Oncogene. 2002;21:2593–604.

    Article  CAS  PubMed  Google Scholar 

  56. Ueda H, Ullrich SJ, Gangemi JD, Kappel CA, Ngo L, Feitelson MA, Jay G. Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet. 1995;9:41–7.

    Article  CAS  PubMed  Google Scholar 

  57. Kim CM, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature. 1991;351:317–20.

    Article  CAS  PubMed  Google Scholar 

  58. Chisari FV, Isogawa M, Wieland SF. Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris). 2010;58:258–66.

    Article  CAS  Google Scholar 

  59. Wang HC, Huang W, Lai MD, Su IJ. Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci. 2006;97:683–8.

    Article  CAS  PubMed  Google Scholar 

  60. Gouas D, Shi H, Hainaut P. The aflatoxin-induced TP53 mutation at codon 249 (R249S): biomarker of exposure, early detection and target for therapy. Cancer Lett. 2009;286:29–37.

    Article  CAS  PubMed  Google Scholar 

  61. Kew MC. Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis. Liver Int. 2003;23:405–9.

    Article  CAS  PubMed  Google Scholar 

  62. Umoh NJ, Lesi OA, Mendy M, et al. Aetiological differences in demographical, clinical and pathological characteristics of hepatocellular carcinoma in the Gambia. Liver Int. 2011;31:215–21.

    Article  PubMed  Google Scholar 

  63. Jiang W, Wang XW, Unger T, Forgues M, Kim JW, Hussain SP, Bowman E, Spillare EA, Lipsky MM, Meck JM, Cavalli LR, Haddad BR, Harris CC. Cooperation of tumor-derived HBx mutants and p53-249(ser) mutant in regulating cell proliferation, anchorage-independent growth and aneuploidy in a telomerase-immortalized normal human hepatocyte-derived cell line. Int J Cancer. 2010;127:1011–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Gouas DA, Shi H, Hautefeuille AH, et al. Effects of the TP53 p.R249S mutant on proliferation and clonogenic properties in human hepatocellular carcinoma cell lines: interaction with hepatitis B virus X protein. Carcinogenesis. 2010;31:1475–82.

    Article  CAS  PubMed  Google Scholar 

  65. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol. 2005;5:215–29.

    Article  CAS  PubMed  Google Scholar 

  66. Foy E, Li K, Sumpter R Jr, Loo YM, et al. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc Natl Acad Sci U S A. 2005;102:2986–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Li K, Foy E, Ferreon JC, et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A. 2005;102:2992–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Majumder M, Ghosh AK, Steele R, Ray R, Ray RB. Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner. J Virol. 2001;75:1401–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. McClain CJ, Hill DB, Song Z, Deaciuc I, Barve S. Monocyte activation in alcoholic liver disease. Alcohol. 2002;27:53–61.

    Article  CAS  PubMed  Google Scholar 

  70. Hoek JB, Pastorino JG. Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol. 2002;27:63–8.

    Article  CAS  PubMed  Google Scholar 

  71. Lambert MP, Paliwal A, Vaissiere T, et al. Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake. J Hepatol. 2011;54:705–15.

    Article  CAS  PubMed  Google Scholar 

  72. Marrogi AJ, Khan MA, van Gijssel HE, et al. Oxidative stress and p53 mutations in the carcinogenesis of iron overload-associated hepatocellular carcinoma. J Natl Cancer Inst. 2001;93:1652–5.

    Article  CAS  PubMed  Google Scholar 

  73. Gu TL, Deng X, Huang F, et al. Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma. PLoS One. 2011;6:e15640.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. International Agency for Research on Cancer. Asbestos. In: IARC monographs on the evaluation of carcinogenic risks to humans, volume 100—a review of human carcinogens, Part B: biological agents. Lyon: International Agency for Research on Cancer; 2012.

    Google Scholar 

  75. Hollstein M, Marion MJ, Lehman T, et al. p53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers. Carcinogenesis. 1994;15:1–3.

    Article  CAS  PubMed  Google Scholar 

  76. Barbin A, Froment O, Boivin S, et al. p53 gene mutation pattern in rat liver tumors induced by vinyl chloride. Cancer Res. 1997;57:1695–8.

    CAS  PubMed  Google Scholar 

  77. Przygodzki RM, Finkelstein SD, Keohavong P, et al. Sporadic and Thorotrast-induced angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2. Lab Invest. 1997;76:153–9.

    CAS  PubMed  Google Scholar 

  78. Dragani TA. Risk of HCC: genetic heterogeneity and complex genetics. J Hepatol. 2010;52:252–7.

    Article  CAS  PubMed  Google Scholar 

  79. Allen KJ, Gurrin LC, Constantine CC, et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med. 2008;358:221–30.

    Article  CAS  PubMed  Google Scholar 

  80. Pujol FH, Navas MC, Hainaut P, Chemin I. Worldwide genetic diversity of HBV genotypes and risk of hepatocellular carcinoma. Cancer Lett. 2009;286:80–8.

    Article  CAS  PubMed  Google Scholar 

  81. Yu MW, Yeh SH, Chen PJ, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst. 2005;97:265–72.

    Article  CAS  PubMed  Google Scholar 

  82. Yang HI, Yeh SH, Chen PJ, et al. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst. 2008;100:1134–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Kuang SY, Jackson PE, Wang JB, et al. Specific mutations of hepatitis B virus in plasma predict liver cancer development. Proc Natl Acad Sci U S A. 2004;101:3575–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Fang ZL, Sabin CA, Dong BQ, et al. Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study. J Gen Virol. 2008;89:2882–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Gao ZY, Li T, Wang J, et al. Mutations in preS genes of genotype C hepatitis B virus in patients with chronic hepatitis B and hepatocellular carcinoma. J Gastroenterol. 2007;42:761–8.

    Article  CAS  PubMed  Google Scholar 

  86. Hsing AW, Rashid A, Devesa SS, Fraumeni JF. Biliary tract cancer. In: Schottenfeld D, Fraumeni JF, editors. Cancer epidemiology and prevention. New York: Oxford University Press; 2006. p. 787–800.

    Chapter  Google Scholar 

  87. Boffetta P, Boccia S, La Vecchia C. A quick guide to cancer epidemiology. New York: Springer; 2014.

    Book  Google Scholar 

  88. Malker HS, McLaughlin JK, Malker BK, et al. Biliary tract cancer and occupation in Sweden. Br J Ind Med. 1986;43:257–62.

    CAS  PubMed  PubMed Central  Google Scholar 

  89. Kuzmickiene I, Didziapetris R, Stukonis M. Cancer incidence in the workers cohort of textile manufacturing factory in Alytus, Lithuania. J Occup Environ Med. 2004;46:147–53.

    Article  PubMed  Google Scholar 

  90. Gamble J. Risk of gastrointestinal cancers from inhalation and ingestion of asbestos. Regul Toxicol Pharmacol. 2008;52. Suppl:S124–53.

    Article  CAS  PubMed  Google Scholar 

  91. Ahrens W, Mambetova C, Bourdon-Raverdy N, et al. Occupational exposure to endocrine-disrupting compounds and biliary tract cancer among men. Scand J Work Environ Health. 2007;33:387–96.

    Article  CAS  PubMed  Google Scholar 

  92. Lin Y, Nishiyama T, Kurosawa M. Association between shift work and the risk of death from biliary tract cancer in Japanese men. BMC Cancer. 2015;15:757.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Johnson ES, Cardarelli K, Jadhav S. Cancer mortality in the meat and delicatessen departments of supermarkets (1950–2006). Environ Int. 2015;77:70–5.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

    Paolo Boffetta

  2. Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy

    Paolo Boffetta

  3. Department of Public Health and Pediatric Sciences, University of Turin, Turin, Italy

    Francesca Donato

  4. Sanofi Pasteur, Lyon, France

    Doriane Gouas

  5. Experimental Medicine and Diagnostics, Global Exploratory Development, UCB BioPharma SPRL, Braine-L’Alleud, Belgium

    André Nogueira da Costa

  6. International Agency for Research on Cancer, World Health Organization, Lyon, France

    Behnoush Abedi-Ardekani

  7. Institute for Advanced Biosciences, University Grenoble Alpes, La Tronche, France

    Pierre Hainaut

Authors
  1. Paolo Boffetta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francesca Donato
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Doriane Gouas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. André Nogueira da Costa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Behnoush Abedi-Ardekani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Pierre Hainaut
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paolo Boffetta .

Editor information

Editors and Affiliations

  1. Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

    Sisko Anttila

  2. Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

    Paolo Boffetta

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Boffetta, P., Donato, F., Gouas, D., da Costa, A.N., Abedi-Ardekani, B., Hainaut, P. (2020). Cancers of the Intestine, the Liver, and the Biliary Tract. In: Anttila, S., Boffetta, P. (eds) Occupational Cancers. Springer, Cham. https://doi.org/10.1007/978-3-030-30766-0_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-30766-0_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-30765-3

  • Online ISBN: 978-3-030-30766-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation